YBX1 and non-small cell lung carcinoma: To further validate the direct binding between YB-1 and CAR10, a RIP assay was conducted using the lysates of NSCLC cells treated with paraformaldehyde [37] and an YB-1 antibody to precipitate CAR10, which was then detected by qRT-PCR using specific primers (Table S6).